{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:30Z","timestamp":1753892010940,"version":"3.41.2"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2023.1283431","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T17:46:16Z","timestamp":1694022376000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Reviews in radiation oncology"],"prefix":"10.3389","volume":"13","author":[{"given":"David Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganapasam","family":"Sudhandiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil D.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24592","article-title":"PSMA PET-based stereotactic body radiotherapy for locally recurrent prostate cancer after definitive first-line therapy","volume":"83","author":"Gruen","year":"2023","journal-title":"Prostate"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1003998","DOI":"10.1371\/journal.pmed.1003998","article-title":"Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial","volume":"19","author":"Parker","year":"2022","journal-title":"PloS Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/02841851221140668","article-title":"PET\/MR versus PET\/CT for locoregional staging of oropharyngeal squamous cell cancer","volume":"64","author":"Flygare","year":"2023","journal-title":"Acta Radiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40644-022-00518-7","article-title":"Variability of radiotherapy volume delineation: PSMA PET\/MRI and MRI based clinical target volume and lymph node target volume for high-risk prostate cancer","volume":"23","author":"Liu","year":"2023","journal-title":"Cancer Imaging"},{"key":"B5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40644-023-00565-8","article-title":"Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, (18)F-FDG PET\/MRI and CA 19-9","volume":"23","author":"Yoo","year":"2023","journal-title":"Cancer Imaging"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. Maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: A phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2017.3406","article-title":"Association of survival with shorter time to radiation therapy after surgery for US patients with head and neck cancer","volume":"144","author":"Harris","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30939","article-title":"Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer","volume":"123","author":"Graboyes","year":"2017","journal-title":"Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1283431\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T17:46:18Z","timestamp":1694022378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1283431\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":10,"alternative-id":["10.3389\/fonc.2023.1283431"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1283431","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"article-number":"1283431"}}